HEALTH POLICY 2022
Article 1: Presentation
Recognizing the unique physical and environmental challenges associated with participation in trail-running events, including but not limited to extreme distances, varying weather conditions, altitude extremes, challenging and potentially unstable terrain and potential for limited visibilities or nighttime participation, the purpose of this Health Policy is to protect participant’s health and increase safety during competition.
This Health Policy supports the health monitoring of participants before the competition and protection of the physical health of participants during the competition.
This Health Policy applies to all participants.
Article 2: Rules
As a condition of participation, each participant agrees to:
2.1 Provide within the framework in use by the Organization, any medical history and/or listing of medical conditions as well as the use of regular treatments, medications (prescription and non-prescription) or food supplements within 30 days before the start of the competition.
2.2 Accept within the framework of this Health Policy to answer any meeting request on site or remotely (phone or videoconference) within 30 days before the start of the competition to address medical concerns and up to 15 days after the competition to address any health concerns or health and safety related testing results.
2.3 Comply with the prohibited list published annually by the World Anti-Doping Agency (WADA) and not to use any substances included in the WADA Monitoring Program.
2.4 As a component of health and safety monitoring, accept within the framework of this Health Policy all urine and/or blood and/or capillary and/or saliva samples within 30 days before the start of the competition and up to 15 days after the competition to ensure compliance with this Health Policy knowing that all samples and analyzes costs remain entirely funded by the Organization.
2.5 As a component of health protection and competition safety, the following are not permitted 24 hours prior to and during competition (and may be assessed by urine and/or blood and/or capillary and/or saliva samples)
2.5.1 All painkillers (excluding paracetamol/acetaminophen) including Tramadol
2.5.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) regardless of the mode of administration
2.5.3 Cannabidiols (CBD) for safety reasons.
2.6 Additional health and safety prohibitions
2.6.1 Within 30 days before the start of the competition and during the competition Intravenous iron infusion
2.6.2 Within 7 days before the start of the competition and during the competition
Intravenous infusion (unless associated with a defined medical intervention and with notice to event and review)
2.6.3 Thyroid synthesis hormones except in case of partial or total removal of the thyroid or hypothyroidism of medical origin
COMPETITION’S RULES RELATED TO THE HEALTH POLICY 2022
Breach of rules
In case of:
-Proven breach, refusal, or transmission of erroneous information in connection with this Health Policy.
-Proven breach in connection with the possible use of a substance and/or method not allowed by the Health Policy, in the periods before the competition or during the competition, mainly on the basis of the analyzes carried out within the framework of this Health Policy.
- Medical condition incompatible with participation and/or continuation in the competition by pre-screening of health information and/or any other way of investigation.
The participant agrees to accept decisions or sanctions from the Organization which may range as examples from a non-participation before the competition or from a simple warning to downgrading after the competition.
The nature of the decisions or sanctions will have to be established in particular according to the "Elite" or "Regular" status of the participant concerned in relation to the information received before the competition, a first breach or not in theses Health Policy rules, as well as on the possible prescription, directly from the medical team of the competition, of an unauthorized substance and/or method stated in this Health Policy.
The classification of a participant in the "Elite" or "Regular" category will be defined by the Organization but will include at least the first 10 Men and the first 10 Women in the general ranking as well as the first 3 Men and the first 3 Women in each age group ranking.